Chronic Myeloid Leukemia Treatment Discontinuation
2 意见
• 06/27/23
0
0
嵌入
The panelists, Jorge Cortes, MD; Kevin Kelly, MD, PhD; David Snyder, MD, FACP; Harry Erba, MD, PhD; and Javier Pinilla-Ibarz, MD, PhD, discuss under what conditions treatment discontinuation may be considered in the management of chronic myeloid leukemia.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论